KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Assets Average (2016 - 2025)

Gilead Sciences' Assets Average history spans 17 years, with the latest figure at $58.8 billion for Q4 2025.

  • For Q4 2025, Assets Average rose 3.56% year-over-year to $58.8 billion; the TTM value through Dec 2025 reached $58.8 billion, up 3.56%, while the annual FY2025 figure was $59.0 billion, 2.56% down from the prior year.
  • Assets Average reached $58.8 billion in Q4 2025 per GILD's latest filing, up from $57.1 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $67.9 billion in Q1 2021 to a low of $54.1 billion in Q3 2024.
  • Average Assets Average over 5 years is $61.4 billion, with a median of $62.3 billion recorded in 2023.
  • Peak YoY movement for Assets Average: increased 17.12% in 2021, then fell 13.32% in 2024.
  • A 5-year view of Assets Average shows it stood at $67.5 billion in 2021, then fell by 6.9% to $62.9 billion in 2022, then fell by 0.98% to $62.2 billion in 2023, then decreased by 8.82% to $56.8 billion in 2024, then grew by 3.56% to $58.8 billion in 2025.
  • Per Business Quant, the three most recent readings for GILD's Assets Average are $58.8 billion (Q4 2025), $57.1 billion (Q3 2025), and $56.1 billion (Q2 2025).